Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
598.00    -11.00 (-1.81%)
Bid:
597.00
Ask:
599.00
Spread: 2.00 (0.335%)
Market Cap: £521.00m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Director/PDMR Shareholding

17 Apr 2009 15:13

RNS Number : 7768Q
Victrex PLC
17 April 2009
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).

Β 

(1)

AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should completeΒ boxes 1 to 16, 23 and 24.

(2)

AnΒ issuerΒ making a notification in respect of a derivative relating to theΒ sharesΒ of theΒ issuerΒ should completeΒ boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.Β 

(3)

AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should completeΒ boxes 1 to 3Β and 17 to 24.Β 

(4)

AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β 

Β 

Please complete all relevant boxes in block capital letters.

1. Name of theΒ issuer

VICTREX PLC

………………………………

2. State whether the notification relates to (i) a transaction notified in accordance withΒ DRΒ 3.1.4R(1)(a); or

(ii)Β DRΒ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; orΒ 

(iii) both (i) and (ii)

(iii) Β MR TIMOTHY WALKER

(i) MR ANDREW STEPHEN BARROW

(i)Β  Β MRΒ DAVID JOHN YAXLEY

………………………………

3. Name ofΒ person discharging managerial responsibilities/director

MR TIMOTHY WALKER

MR ANDREW STEPHEN BARROW

MRΒ DAVID JOHN YAXLEY

………………………………

4. State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

NO

………………………………

5. Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

AS ABOVE

………………………………

6. Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

ORDINARY SHARES OF 1P EACH

………………………………

7. Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

HILL SAMUEL AESOPΒ 

………………………………

8 State the nature of the transaction

MONTHLY AESOP PURCHASE

………………………………

9. Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

MR TIMOTHY WALKERΒ  23

MR ANDREW STEPHEN BARROWΒ  23

MRΒ DAVID JOHN YAXLEY 23

………………………………

10. Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

N/A

………………………………

11. Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

N/A

………………………………

12. Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β 

N/A

………………………………

13. Price perΒ shareΒ or value of transaction

Β£5.37

………………………………

14. Date and place of transaction

16Β AprilΒ 2009

………………………………

15. Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)

MR TIMOTHY WALKERΒ  102,953Β = 0.12%

MR ANDREW STEPHEN BARROWΒ  1,954Β = N/A

MRΒ DAVID JOHN YAXLEY 1,589Β = N/A

………………………………

16. Date issuer informed of transaction

17Β AprilΒ 2009

………………………………

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

17. Date of grant

………………………………

18. Period during which or date on which it can be exercised

………………………………

19. Total amount paid (if any) for grant of the option

………………………………

20. Description ofΒ sharesΒ or debentures involved (classΒ and number)

………………………………

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

………………………………

22. Total number ofΒ sharesΒ or debentures over which options held following notification

………………………………

23. Any additional information

………………………………

24. Name of contact and telephone number for queries

Claire Salisbury

01253 8977477

………………………………

Name and signature of duly authorised officer ofΒ issuerΒ responsible for making notification

Claire Salisbury

………………………………

Date of notification

17 AprilΒ 2009

………………………………

ENDΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSMGGMDDNFGLZM
Date   Source Headline
24th Jun 20249:44 amRNSHolding(s) in Company
14th Jun 20249:00 amRNSAdditional Listing
3rd Jun 20242:19 pmRNSBlock listing Interim Review
3rd Jun 20249:30 amRNSDirector/PDMR Shareholding
31st May 202411:23 amRNSTotal Voting Rights
23rd May 20247:00 amRNSSBTI approval of carbon reduction targets
15th May 20243:59 pmRNSDirector/PDMR Shareholding
14th May 20244:05 pmRNSDirector/PDMR Shareholding
13th May 20247:00 amRNSVictrex plc - Interim Results 2024
7th May 20243:25 pmRNSDirector Declaration
30th Apr 20242:54 pmRNSTotal Voting Rights
28th Mar 20249:56 amRNSTotal Voting Rights
15th Mar 20248:30 amRNSDirectorate Change
6th Mar 20242:06 pmRNSDirector/PDMR Shareholding
29th Feb 20249:36 amRNSTotal Voting Rights
21st Feb 20248:00 amRNSBlock listing Interim Review
9th Feb 202412:16 pmRNSResult of AGM
9th Feb 20247:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202412:26 pmRNSTotal Voting Rights
25th Jan 202410:57 amRNSHolding(s) in Company
9th Jan 202412:13 pmRNSAnnual Report & Accounts
29th Dec 20239:00 amRNSTotal Voting Rights
12th Dec 202310:21 amRNSDirector/PDMR Shareholding
5th Dec 20232:42 pmRNSDirector/PDMR Shareholding
5th Dec 20232:33 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSVictrex plc - Preliminary Results 2023
1st Dec 202310:41 amRNSBlock listing Interim Review
30th Nov 202311:10 amRNSTotal Voting Rights
3rd Nov 20231:31 pmRNSHolding(s) in Company
31st Oct 20239:36 amRNSTotal Voting Rights
19th Sep 20231:59 pmRNSDirector/PDMR Shareholding
8th Sep 20239:32 amRNSHolding(s) in Company
31st Aug 20239:30 amRNSTotal Voting Rights
23rd Aug 202310:52 amRNSHolding(s) in Company
17th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20239:39 amRNSTotal Voting Rights
18th Jul 202311:51 amRNSDirector/PDMR Shareholding
13th Jul 20232:00 pmRNSAdditional Listing
6th Jul 20237:00 amRNSVictrex plc - Q3 Interim Management Statement
3rd Jul 20234:03 pmRNSHolding(s) in Company
30th Jun 20239:37 amRNSTotal Voting Rights
27th Jun 202310:08 amRNSDirector/PDMR Shareholding
19th Jun 20232:27 pmRNSDirector/PDMR Shareholding
14th Jun 20237:00 amRNSTrading Statement
1st Jun 202312:08 pmRNSBlock listing Interim Review
31st May 20239:52 amRNSTotal Voting Rights
17th May 202310:55 amRNSDirector/PDMR Shareholding
16th May 202310:03 amRNSDirector/PDMR Shareholding
12th May 202310:37 amRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.